Colombia vs Tunisia: Cause of death, by non-communicable diseases, female
Colombia
66.3%
in 2021
Tunisia
65.4%
in 2021
Colombia rank
104th
Tunisia rank
106th
Cause of death, by non-communicable diseases, female over time
- Colombia
- Tunisia
How they compare
Colombia currently reports 66.3% against 65.4% in Tunisia, a difference of 0.9%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tunisia ahead.
Colombia ranks 104th and Tunisia ranks 106th of 185 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.7% | 78.5% | 2.8% | Tunisia |
| 2010s | 83.8% | 86.8% | 3.0% | Tunisia |
| 2020s | 69.9% | 75.2% | 5.3% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Colombia or Tunisia?
- Colombia, at 66.3% against 65.4% in Tunisia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Colombia and Tunisia?
- 0.9%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Tunisia?
- 6 years are reported by both, from 2000 to 2021.
- How do Colombia and Tunisia rank globally for cause of death, by non-communicable diseases, female?
- Colombia ranks 104th and Tunisia ranks 106th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.